Morbidity and mortality for women with COPD is increasing. This systematic review uncovers how women seem to experience COPD differently to men, and helps health care professionals to provide an individualised approach to caring for these patients.
Updated NICE guideline of type 2 diabetes management in adults
Professor Mike Kirby highlights the key updates in the new NICE guidelines on the management of type 2 diabetes in adults and how these impact your practice. The updated guideline focuses on an individualised approach to patient care with recommendations on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
An innovative strategy for the management of chronic heart failure
A large amount of evidence points to the effectiveness of optimising primary care heart failure management in reducing referral to hospital and improving outcomes for patients. This article describes the changes made in a primary care practice that has resulted in measurable difference for the primary care team and their patients.
Is high-intensity interval exercise effective?
Despite good evidence that physical activity is effective in preventing health complications, less than half of adults meet the minimum recommendations for physical activity. This article reviews the use and value of high-intensity interval exercise (short bursts of exercise) in different groups to reduce the risk of long-term conditions.
How effective are SGLT-2 inhibitors in treating diabetes?
Dr David Haslam, chair of the UK’s National Obesity Forum, provides a useful review of SGLT-2 inhibitors and their ability to lower glucose level, body weight and blood pressure in people with type 2 diabetes.
How to improve AF-related stroke prevention
Recent guidelines recommend two key steps to reduce ischaemic stroke in people with atrial fibrillation: 1. Improving the assessment of stroke risk and 2. Increasing the use of evidence-based anticoagulant therapy. In this article, leading specialists explain how to apply current guidelines to improve current practice in stroke prevention.
What’s new in FH genetics?
Recent advances in next generation sequencing (NGS) have reduced costs and made genetic diagnosis of familial hypercholesterolaemia (FH) quicker. This article reviews some of the technological breakthroughs in DNA testing in FH and benefits to patients and clinicians.
HEART UK – The Cholesterol Charity – has provided editorial support and review of this sponsored FH series.This article was made possible by an unrestricted educational grant by Sanofi, who had no control over content.
The effective management of gout
This article provides an overview of gout, including its optimal treatment, links with cardiovascular disease and the value of European and UK guidelines.
E-cigarettes: key issues and potential impact on public health
Electronic cigarettes, e-cigs, vaporisers and the various other names given to these new devices have become a phenomenon. Their popularity over the past few years has grown significantly, with an expansion of highstreet e-cigarette shops, marketing via the internet and social media, as well as traditional approaches using print advertisement and mass media campaigns. Despite their increasing usage largely by smokers and ex-smokers, e-cigarettes have divided opinion as to whether they can offer real benefits or they are potentially damaging to public health. While a recent Public Health England review concluded that e-cigarettes could be prescribed to help smokers to quit, the Welsh government plans to restrict their use in the same way as for conventional cigarettes. This paper will present some of the main issues that surround e-cigarettes and highlight the potential consequences good and bad that this new technology may bring.
Health-related quality of life among atrial fibrillation patients at diagnosis and one year later
Therapeutic interventions in atrial fibrillation primarily aim at reducing symptoms and improving or maintaining patients’ health-related quality of life (HRQoL). As most studies in this area have focused on randomised trial populations with highly symptomatic patients, this large observational study aims to assess HRQoL in a typical UK general practice setting.
Optimising medical therapy for stable angina patients
Percutaneous coronary intervention (PCI) has no benefit over optimising medical therapy (OMT) in the management of patients with chronic stable angina. Guidelines recommend an initial OMT approach; however, the use of medicines remains suboptimal. The aim of this study was to test whether a primary care clinical pharmacist service could enhance the management of patients with chronic stable angina.
Optimising the management of heart failure
Heart failure (HF) is an important cause of morbidity, mortality and misery for patients. However, there are many ways to improve and extend the lives of people with HF, if clinicians are familiar with and apply the numerous traditional, less mainstream and more innovative evidence-based treatment options. This article reviews current best practice in the management of chronic HF and of acute decompensated HF, and considers recent insights, controversies and innovations in this important, fast moving field.
